Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 24Neoplasm Metastasis 6Colonic Neoplasms 6Stomach Neoplasms 5Rectal Neoplasms 5Carcinoma, Hepatocellular 4Cholangiocarcinoma 3Carcinoma, Non-Small-Cell Lung 3Biliary Tract Neoplasms 3Adenocarcinoma Of Esophagus 3Unresectable Metastatic Colorectal Cancer 2Recurrence 2Neoplastic Cells, Circulating 2Neoplasms 2Gastrointestinal Neoplasms 2Adenocarcinoma 2Squamous Cell Carcinoma of Head and Neck 1Solid Tumors 1Ovarian Neoplasms 1Oligometastatic Gastric Adenocarcinoma 1Neoplasms, Second Primary 1Neoplasm, Residual 1Margins of Excision 1Lung Neoplasms 1Locally-advanced Rectal Cancer 1Locally Advanced Colorectal Carcinoma 1Hyperthermia 1Gastroesophageal Junction Adenocarcinoma 1Gastroesophageal Adenocarcinoma 1Gallbladder Neoplasms 1

Interventions

Neoadjuvant Therapy 1Microscopy, Confocal 1Indocyanine Green 1IFL protocol 1Folfox protocol 1Drug Combinations 1Chemoradiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Margins of Excision × Folfox protocol × Clear all
NCT04389086 2022-09-06

PelvEx II

Catharina Ziekenhuis Eindhoven

Phase 3 Recruiting
364 enrolled
Gastrointestinal

Margins of Excision, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡